"Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency.
Patients with LAL deficiency (also known as Wolman disea"...
Patients should be advised that:
- Some people, particularly children, may experience difficulties swallowing the ALBENZA tablets whole. ALBENZA chewable tablet is available for children and patients who may be unable to swallow a tablet.
- Take ALBENZA with food.
- ALBENZA may cause fetal harm, therefore, obtain a pregnancy test in women of reproductive potential prior to initiating therapy.
- Advise women of reproductive potential to use effective birth control while on ALBENZA and for one month after completing treatment.
- During ALBENZA therapy, monitor blood counts and liver enzymes every 2 weeks because of the possibility of harm to the liver or bone marrow.
Last reviewed on RxList: 6/29/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Albenza Information
Albenza - User Reviews
Albenza User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.